Socio-Economic Status and Hemoglobin Concentration of Type 2 Diabetes
Mellitus Patients Attending Diabetic Clinic in Benin City, Nigeria
143
on the Diagnosis and Classification of Diabetes Mellitus,”
Diabetes Care, Vol. 20, 1997, pp. 1183-1197.
[4] World Health Organization, “Expert Committee on the
Diagnosis and Classification of Diabetes Mellitus. Follow
up Report on the Diagnosis of Diabetes Mellitus,” Dia-
betes Care, Vol. 26, No. 11, 2003, pp. 3160-3167.
http://dx.doi.org/10.2337/diacare.26.11.3160
[5] S. Chinenye, D. I. Uchenna, C. N. Unachukwu, A. O.
Ogbera and A. C. Ojule, “The Pattern of Diabetes Melli-
tus in Rivers State, Nigeria,” Nigerian Endocrine Prac-
tice, Vol. 2, 2008, pp. 87-93.
[6] A. A. Motala, “Diabetes Trends in Africa,” Diabetes/
Metabolism Research and Reviews, Vol. 18, Suppl. 3,
2002, pp. 514-520.
[7] S. Vigan, “Type 2 Diabetes,” Annals of Internal Medicine,
Vol. 152, No. 5, 2010, p. 31.
[8] S. H. Sayolah, M. Miret, J. Sung, C. Varas, D. Gause and
F. L. Brancati, “Post Challenge Hyperglycemia and Mor-
tality in a National Sample of U.S Adults,” Diabetes Care,
Vol. 24, No. 8, 2001, pp. 1397-1402.
[9] A. Osibogun, “The Medicine for Poverty: An Argument
for Health and Development. The Ninth Sir Samuel Ma-
nuwa Lecture,” 36th Annual General and Scientific Meet-
ing, West African College of Physicians (Nigeria Chap-
ter), Uyo, 2012.
[10] “Health Report,” WHO Regional Office, WHO, Brazza-
ville, 2006.
[11] O. O. Ainkugbe, “Non Communicable Disease in Nigeria:
National Survey (Final Report) on Hypertension, Coro-
nary Heart Disease, Diabetes Mellitus Hemoglobinopa-
theis, GGPD Deficiency and Anemia. National Expert
Committee on Non-Communicable Disease,” Federal Mi-
nistry of Health and Social Services, Lagos, 1997.
[12] A. A. Motala, T. Esterhrizen and E. Gouwa, “Diabetes
and Other Disorders of Glycaemia in a South African
Community: Prevalence and Associated Risk Factor,”
Diabetes Cares, Vol. 31, No. 9, 2008, pp. 1783-1788.
[13] K. Rossing, P. K. Christensen, P. Hovind, L. Tarnow, P.
Rossing and H. H. Parving, “Progression of Nephropathy
in Type 2 Diabetic Patients,” Kidney International, Vol.
66, No. 4, 2004, pp. 1596-1605.
http://dx.doi.org/10.1111/j.1523-1755.2004.00925.x
[14] World Health Organization, “Worldwide Prevalence of
Anemia,” WHO, Geneva, 2008.
[15] L. Naing, T. Winn and B. N. Rusli, “Practical Issues in
Calculating the Sample Size for Prevalence Studies,” Ar-
chives of Orofacial Sciences, Vol. 1, 2006, pp. 9-14.
[16] D. Barham and P. Trinder, “An Improved Colour Reagent
for the Determination of Blood Glucose by the Oxidase
System,” Analyst , Vol. 97, 1972, pp. 142-145.
http://dx.doi.org/10.1039/an9729700142
[17] J. Dacis and D. Lewis, “Practical Hematology,” 8th Edi-
tion, Churchill Livingstone, London, 2006, pp. 27-30.
[18] K. G. Alberti, P. Zimmet and I. Shaw, “International Dia-
betes Federation: A Consensus on Type 2 Diabetes Pre-
vention,” Diabetes Medicals, Vol. 24, No. 5, 2007, pp.
451-468.
http://dx.doi.org/10.1111/j.1464-5491.2007.02157.x
[19] Diabetes Care and Research in Europe, “The Saint Vin-
cent. Declaration,” Diabetic Medicals, Vol. 7, 1990, p.
360.
http://dx.doi.org/10.1111/j.1464-5491.1990.tb01405.x
[20] World Health Organization, “Prevalence of Diabetes
Mellitus. Report of a WHO Study Group,” WHO, No 844.
1994.
[21] K. Rossing, P. K. Christensen, P. Hovind, et al., “Pro-
gression of Nephropathy in Type 2 Diabetic,” Kidney In-
ternational, Vol. 66, 2004, pp. 1596-1605.
http://dx.doi.org/10.1111/j.1523-1755.2004.00925.x
[22] P. K. Ranil, R. Raman and S. R. Rachepalli, “Anemia and
Diabetic Retinopathy in Type 2 Diabetes Mellitus,” Jour-
nal of Association of Physicians India, Vol. 58, 2010, pp.
91-94.
[23] J. P. New, I. Aung and P. G. Baker, “The High Preva-
lence of Unrecognized Anemia in Patients with Diabetes
and Chronic Kidney Disease: A Population Based Study,”
Diabetes Medicine, Vol. 25, No. 5, 2008, pp. 564-569.
http://dx.doi.org/10.1111/j.1464-5491.2008.02424.x
[24] D. R. Bosman, C. A. Osborn, J. T. Marsden, I. C. Mac-
dougall, W. N. Gardner and P. Watkins, “Erythropoietin
Response to Hypoxia in Patients with Diabetic Auto-
nomic Neutropathy and Non Diabetic Chronic Renal Fail-
ure,” Diabetic Medical, Vol. 19, No. 1, 2002, pp. 65-69.
http://dx.doi.org/10.1046/j.1464-5491.2002.00634.x
[25] G. A. Kaysen, “The Microinflammatory State in Uremia:
Causes and Potential Consequences,” Journal of the
American Society of Nephrology, Vol. 12, 2001, pp. 1549-
1557.
[26] M. Goicoechea, J. Martin, P. De Sequera, J. A. Qunoga,
A. Ortiz, V. Carreno and C. Caramelo, “Role of Cyto-
kines in the Response to Erythropoietin in Hemo Dialysis
Patients,” Kidney International, Vol. 54, No. 4, 1998, pp.
1337-1343.
http://dx.doi.org/10.1046/j.1523-1755.1998.00084.x
[27] E. O. Zanjani, P. B. McGlave, S. F. Davies, M. Banisadre,
M. E. Caplan and G. A. Sarosi, “In Vitro Suppression of
Erythropoiesis by Bone Marrow Adherent Cells from
Some Patients with Fungal Infection,” British Journal of
Hematology, Vol. 50, No. 3, 1998, pp. 479-490.
[28] D. R. Bosman, A. S. Winkler, J. T. Marsden, I. C. Mac-
dousall and P. J. Watkins, “Anemia with Erythropoietin
Deficiency Occurs Early in Diabetic Nephropathy,” Dia-
betes Care, Vol. 24, No. 3, 2001, pp. 495-499.
http://dx.doi.org/10.2337/diacare.24.3.495
[29] J. C. Kathrine, D. W. Joh, G. R. Stephen, S. Hilary, R. O.
David, W. Debbie, C. Ivor and O. P. Aled, “Anemia and
Diabetes in the Absence of Nephtropathy,” Diabetes Care,
Vol. 28, No. 5, 2005, pp. 1118-1123.
Copyright © 2013 SciRes. OJPathology